Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 34 results for "Novartis Company"

Novartis India's board meeting on February 03, 2017

Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 03, 2017, to consider unaudited financial results of the Company for third quarter and nine months ended December 31, 2016. Money Control, 1 month ago

142 images for Novartis Company

Lets Recycle, 3 weeks ago
Business Insider, 3 weeks ago
Reuters UK, 3 weeks ago
Sify, 3 weeks ago
Yahoo! Finance UK and Ireland, 3 weeks ago
Dotemirates.com, 1 month ago
Yahoo! UK and Ireland, 3 weeks ago
4 Traders, 3 weeks ago
Reuters UK, 4 weeks ago
Yahoo! News, 4 weeks ago
catchnews.com

Sun Pharma gains after buying Novartis' cancer drug Odomzo

Sun Pharmaceutical Industries rose 0.42% to Rs 617 at 11:18 IST on BSE after the company announced its plans to acquire a branded oncology product, Odomzo, from Novartis.
 Business Standard2 months ago Sun Pharma to acquire cancer product Odomzo from Novartis for $175 million  catchnews.com2 months ago Sun Pharma to acquire oncology product from Novartis for $175m  Business Standard2 months ago

Sun Pharma to acquire Novartis’ cancer drug

An agreement has been signed between subsidiaries of both companies and the deal will close following anti-trust clearance and other closing conditions. Switzerland-based Novartis AG will get an additional milestone payment from Sun Pharma as per the deal ...
 The Hindu2 months ago
Money Control

Drugmakers in Davos shift focus to chronic diseases of poor

Twenty-two companies, including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank.
 Money Control1 month ago
Reuters

Novartis says Votubia receives EU approval for new indication

Novartis has broaded the indications for its Votubia drug, the company said on Tuesday, when the European Union approved its use to treat refractory partial-onset seizures in patients with tuberous sclerosis complex. Votubia is the first adjunctive treatment ...
 Reuters3 weeks ago
Sify

Trump to meet Novartis CEO, other pharma bosses on Tuesday

By John Miller (Reuters) - U.S. President Donald Trump, who has accused drugmakers of "getting away with murder" on prices, will meet executives from the pharmaceutical industry at the White House on Tuesday. Switzerland's Novartis said its chief executive ...
 Sify3 weeks ago Indian pharma's Trump fears  Rediff.com3 weeks ago Trump pushes drugmakers for lower prices, more U.S. production  Sify3 weeks ago
Sify

European blue chip stocks offer great income opportunities - Barron's

By Jarrett Renshaw NEW YORK (Reuters) - European blue-chip stocks Nestle, Royal Dutch Shell, Novartis and Unilever are expected to be among the best income-producing stocks of 2017, Barron's said in a report. Many European companies offering dividends ...
 Sify1 month ago
Reuters

Novartis says court battle will delay its Enbrel copy until 2018 at least

The Novartis copy of Amgen's blockbuster psoriasis drug Enbrel will not go on sale before 2018 at the earliest because of the U.S. company's patent protection challenge, the Swiss drugmaker's head of generics told Reuters. Though the U.S. Food and Drug ...
 Reuters4 weeks ago
Reuters

Colombia cuts price of Novartis cancer drug by 44 percent

Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs after failed price negotiations with the Swiss company. Novartis will be legally obliged to sell the drug, which is used to treat ...
 Reuters2 months ago Novartis says 82 percent of leukemia patients in remission after CAR-T  Reuters2 months ago
Reuters

Conatus to receive $50 million in liver drug deal with Novartis

Swiss drugmaker Novartis on Monday said it signed a licensing deal to co-develop a fatty liver disease drug with Conatus Pharmaceuticals Inc, under which the small U.S. company will receive $50 million up front. The agreement will enable the companies to ...
 Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less